Register
Login:
Share:
Email Facebook Twitter

EXCLUSIVE: Video presentations from MySQUAR, My Pay, Consilium and Kryptonite1 are now available here Watch here

EXCLUSIVE: David Lenigas answers investor questions in a detailed interview about UKOG, Doriemus, LGC Capital, AfriAg and Angus Energy.


Premaitha Share Chat (NIPT)



Share Price: 7.125Bid: 7.00Ask: 7.25Change: -0.25 (-3.39%)Faller - Premaitha
Spread: 0.25Spread as %: 3.57%Open: 7.375High: 7.375Low: 7.125Yesterday’s Close: 7.375


Share Discussion for Premaitha


Thread View

Please login or register to post a message on Share Chat.

Posts per page:


Grapevinez
Posts: 433
Off Topic
Opinion:No Opinion
Price:7.125
RE: Decision date?
Today 16:05
I believe decision will be made first half of November.
As per Twixs previous post
 
Stubot
Posts: 23
Off Topic
Opinion:No Opinion
Price:7.25
Decision date?
Today 15:53
I've been checking in here on and off for the past few months (I am yet to invest), but lost track recently on the court decision - when is it expected? Is there a 'cut off' date?
Grapevinez
Posts: 433
Off Topic
Opinion:No Opinion
Price:7.25
RE: Im out
Today 15:17
Thanks Flipper.
So Premaitha realistically are Thermos only real offering towards NIPT and sequencer sales.

I still can not get past if they want to supercharge Premaithas sales why not just buy Premaitha and use their war chest of money to get it moving much much faster?
Surely it must be painful for them to watch us plod along scraping a few quid here and there?
Thermo have sales of 20 billion a year!

Let's hope when this is put to bed soon and everyone starts to makes some money because that is why we are all here.
notaflipper
Posts: 487
Off Topic
Opinion:No Opinion
Price:7.25
RE: Im out
Today 15:10
You guys still don’t understand the game plan here…

The size of the NIPT market is potentially $2.62bn in 2020. The size of the sequencer market upon which the NIPT tests run on is valued to be $20bn. So Illumina are interested in promoting their NIPT test over others because it converts labs onto their sequencer platforms. If you look at their sequencer ranges, they have been introducing new sequencers at every price point in order to present an Apple-like marketing strategy. Get them on your platform and up-sell.

Premaitha was positioned for take-out from inception by putting their test on TMO sequencers, hence no settlement possible whilst Illumina were insisting on Premaitha to switch to Illumina sequencers exclusively as it would **** off TMO. The value of having a CE-IVD NIPT is like having “Angry Birds” working on only Samsung or Apple phones. Who gets it sells more phones or sequencers in this case.

That’s why TMO will want to super charge Premaitha’s sales after the litigation whether they buy or not. Get it!
nightera
Posts: 431
Off Topic
Opinion:No Opinion
Price:7.25
RE: SP
Today 14:58
bakky...............That is 100% what is happening with sp,as long as mm`s get sellers the price will drop.

If it drops more even I will buy more.......although enough is enough we will see.
bakky
Posts: 4,783
Off Topic
Opinion:No Opinion
Price:7.25
RE: Im out
Today 14:51
not sure if Thermo need or want to buy Prem, maybe happy with how it is.Yes Grape, I think a lot are waiting for the outcome before piling in, quite happy to miss 10/15% of the upswing for more certainty.Yes Flipper, 5% of $2.62billion, wow! Looking at it like that maybe Thermo will be in for it sometime?
Grapevinez
Posts: 433
Off Topic
Opinion:No Opinion
Price:7.25
RE: Im out
Today 14:18
It has to be the litigation holding this back I know that is stating the obvious but I guess it is still a risk many an investor is not willing to take on.

As you say quite clearly we are selling and will turn a good profit which is more than can be said for many a scam of an AIM listed company.

I think going by what we know as facts regardless of the litigation verdict this should be at least 24p if we win the case and it is put to bed then into the 30s.

There is just no volume here currently but I personally see this as a good time to increase my holding as I am in no rush and believe this will reward me well.

A change in sentiment is long overdue we have a good product and we are being backed by a big player in this market.

It is what it is and no doubt the SP will probably fall after this comment.
Bakky has a good saying about the transfer of wealth from the impatient to the patient and all being well we should not have too much longer to wait.

Flipper you mentioned Thermo having to show their hand by Christmas I recall do you feel Thermo will buy them after verdict should it go our way ?
cuddothisnow
Posts: 814
Off Topic
Opinion:No Opinion
Price:7.25
RE: Im out
Today 14:08
If the price aint moving its dead money. Hence MERL and GKP. Did well over there hence can afford the hit here!
notaflipper
Posts: 487
Off Topic
Opinion:No Opinion
Price:7.25
RE: Im out
Today 14:03
I'm baffled on how to respond to this irrational investment logic going on here. With 50k volume sales, Premaitha would have approximately 5% of a global NIPT market worth 2.62bn USD is 2021.

Even in the even of a hostile takeout Thermo Fisher would want to exercise their Warrants which would guarantee a TO of 26p. Even the IP worth to get to this stage is rivalling the market capitalisation at this sp level. With 26% of shares owned by Directors and them having options over 20p and dealings over 18p they've already shown their confidence
Grapevinez
Posts: 433
Off Topic
Opinion:No Opinion
Price:7.25
RE: Im out
Today 14:03
Think his was a case of premature pump syndrome.
Got to admire the commitment




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.